Nantahala Capital Management’s Evoke Pharma EVOK Stock Holding History

Nantahala Capital Management’s Portfolio EVOK Stock Details EVOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-148,153	Closed	-$736K	–	163
2025 Q3	$736K	Hold	148,153	–	–	0.03%	145
2025 Q2	$385K	Hold	148,153	–	–	0.02%	147
2025 Q1	$407K	Sell	148,153 -41	-0%	-$174	0.02%	135
2024 Q4	$655K	Buy	148,194 +91,945	+163%	+$458K	0.03%	124
2024 Q3	$268K	Sell	56,249 -1	-0%	-$5	0.01%	127
2024 Q2	$357K	Hold	56,250	–	–	0.02%	117
2024 Q1	$412K	Buy	+56,250	New	+$478K	0.02%	109

Nantahala Capital Management's EVOK Position: Q4 2025 in Review

Nantahala Capital Management sold out of Evoke Pharma (EVOK) in Q4 2025, closing a stake of 148,153 shares — an estimated $736K sold.

Nantahala Capital Management first reported a position in EVOK in Q1 2024 and held it in 7 quarters. The position peaked at $736K in Q3 2025. 0 funds tracked by Wall St. Rank hold EVOK as of Q4 2025.

Nantahala Capital Management reported no remaining Evoke Pharma position as of Q4 2025 after selling out during the quarter.
Nantahala Capital Management sold 148,153 Evoke Pharma shares in Q4 2025, an estimated $736K.
Nantahala Capital Management first reported a position in Evoke Pharma in Q1 2024 and held it in 7 quarters.
Nantahala Capital Management's Evoke Pharma position peaked at $736K in Q3 2025.
0 funds tracked by Wall St. Rank held Evoke Pharma as of Q4 2025.

Based on Nantahala Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.